Shelter Pharma
Shelter Pharma (SHELTER) share price was ₹39.60 at the 28 Oct 2026 close; market capitalisation ₹66.65 Cr; sector Healthcare. The share price fell 2.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue rose 49.8% year on year to ₹39.84 Cr and net profit was ₹4.53 Cr, against ₹3.70 Cr a year earlier (compared with Mar 2025). Promoters held 44.60% of Shelter Pharma in Sep 2026, up 0.22 percentage points from Mar 2026. Its Tapetide Score is 66/100 (Strong) as of 28 Oct 2026.
Key Fundamentals
SMEPharmaceuticals & BiotechnologyHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Pharmaceuticals
| ₹1,768.20 | 35.08 | 4,24,250 Cr | 5.08 | 0.91% | 13.79% | 17.94% | 61,848 Cr | 12,117 Cr | |
| ₹9,670.00 | 87.77 | 2,56,708 Cr | 15.32 | 0.32% | 15.32% | 18.96% | 11,682 Cr | 2,925 Cr | |
| ₹4,609.00 | 72.35 | 1,75,312 Cr | 9.54 | 0.82% | 12.16% | 9.06% | 17,058 Cr | 2,156 Cr | |
| ₹2,187.60 | 108.08 | 1,18,199 Cr | 22.30 | 0.09% | 16.38% | 19.67% | 7,323 Cr | 1,090 Cr | |
| ₹1,181.00 | 26.28 | 1,17,805 Cr | 4.35 | 0.09% | 16.99% | 19.24% | 28,515 Cr | 4,593 Cr | |
| ₹1,339.00 | 34.68 | 1,11,764 Cr | 2.88 | 0.61% | 10.87% | 13.94% | 34,247 Cr | 3,184 Cr | |
| ₹1,364.90 | 32.70 | 1,10,265 Cr | 3.12 | 0.96% | 11.21% | 14.88% | 28,589 Cr | 3,356 Cr | |
| Shelter Pharma (this company) | — | — | 67 Cr | 0.92 | 0.84% | 11.78% | 15.97% | — | — |
| Median 8 companies | ₹1,768.20 | 35.08 | 1,18,002 Cr | 4.72 | 0.72% | 12.98% | 16.96% | 28,515 Cr | 3,184 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 84/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 1.00 times its book value
Weaknesses
2- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last 3 years: -12.3%
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin 16.24% · Mar 2026
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 17.02 | 19.13 | 19.31 | 20.71 | 24.06 | 26.6 | 33.29 | 39.84 |
| Expenses | 13.71 | 14.82 | 15.02 | 16.42 | 19.16 | 21.42 | 27.03 | 33.37 |
| Operating Profit | 3.31 | 4.31 | 4.29 | 4.29 | 4.9 | 5.18 | 6.26 | 6.47 |
| OPM % | 19.45% | 22.53% | 22.22% | 20.71% | 20.37% | 19.47% | 18.8% | 16.24% |
| Other Income | 0 | -0.45 | 0 | 0 | 0 | 0 | 0 | 0.01 |
| Interest | 0.01 | 0.01 | 0.05 | 0 | 0.07 | 0.06 | 0.06 | 0.05 |
| Depreciation | 0.08 | 0.08 | 0.12 | 0.13 | 0.1 | 0.17 | 0.19 | 0.22 |
| PBT | 3.22 | 3.77 | 4.12 | 4.16 | 4.73 | 4.95 | 6.01 | 6.21 |
| Tax % | 25.47% | 25.46% | 24.76% | 25% | 25.16% | 25.05% | 25.29% | 27.05% |
| Net Profit | 2.4 | 2.81 | 3.1 | 3.12 | 3.54 | 3.7 | 4.5 | 4.53 |
| EPS (₹) | 3.12 | 3.63 | 2.68 | 2.7 | 3.06 | 3.2 | 3.89 | 2.73 |
Profit & Loss
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.09 | 29.95 | 30.07 | 22.48 | 30.06 | 36.15 | 39.93 | 50.64 | 73.02 |
| Expenses | 27.94 | 30.65 | 29.83 | 22.29 | 27.01 | 28 | 31.14 | 40.57 | 60.29 |
| Operating Profit | 0.15 | -0.7 | 0.24 | 0.19 | 3.05 | 8.15 | 8.79 | 10.07 | 12.73 |
| OPM % | 0.53% | -2.34% | 0.8% | 0.85% | 10.15% | 22.54% | 22.01% | 19.89% | 17.43% |
| Other Income | 0 | 0.83 | 0.01 | 0.01 | 0 | -0.97 | 0 | 0.01 | 0.02 |
| Interest | 0 | 0 | 0.01 | 0.02 | 0.08 | 0.03 | 0.26 | 0.13 | 0.12 |
| Depreciation | 0.1 | 0.07 | 0.13 | 0.12 | 0.17 | 0.16 | 0.25 | 0.27 | 0.41 |
| PBT | 0.05 | 0.06 | 0.11 | 0.06 | 2.8 | 6.99 | 8.28 | 9.68 | 12.22 |
| Tax % | 20% | 16.67% | 27.27% | 33.33% | 26.79% | 25.46% | 25.12% | 25.21% | 26.19% |
| Net Profit | 0.05 | 0.05 | 0.08 | 0.04 | 2.06 | 5.21 | 6.2 | 7.24 | 9.03 |
| EPS (₹) | 0.07 | 0.07 | 0.11 | 0.05 | 2.68 | 6.73 | 5.36 | 6.26 | 5.44 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.45 | 0.45 | 0.45 | 0.48 | 0.48 | 7.74 | 11.56 | 11.56 | 16.61 |
| Reserves | 7.31 | 7.32 | 6.53 | 6.63 | 8.32 | 6.81 | 24.26 | 31.16 | 60.02 |
| Borrowings | 2.07 | 0.11 | 0.24 | 0 | 0.13 | 1.78 | 0.58 | 1.04 | 0.8 |
| Other Liabilities | 1.73 | 3.76 | 3.41 | 3.09 | 3.91 | 5.12 | 1.51 | 4.58 | 6.8 |
| Total Liabilities | 11.56 | 11.64 | 10.63 | 10.2 | 12.84 | 21.45 | 37.91 | 48.34 | 84.23 |
| Fixed Assets | 2.61 | 2.71 | 1.77 | 1.57 | 1.45 | 2.52 | 4.26 | 5.96 | 7.14 |
| CWIP | 0.14 | 0.11 | 0 | 0 | 0.55 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0.68 | 0.68 | 0.68 | 0 | 0 | 0.68 | 0.68 |
| Other Assets | 8.81 | 8.82 | 8.18 | 7.95 | 10.16 | 18.93 | 33.65 | 41.7 | 76.41 |
| Total Assets | 11.56 | 11.64 | 10.63 | 10.2 | 12.84 | 21.45 | 37.91 | 48.34 | 84.23 |
Cash Flow
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 0 | -0.27 | -0.28 | 0.52 | 0 | -1.96 | 5.42 | -12.48 |
| Investing | — | 0 | 0.29 | 0.03 | -0.85 | 0.11 | -4.43 | -7.13 | -14.55 |
| Financing | — | 0 | 0 | 0.48 | 0.06 | 0.21 | 11.01 | 0.09 | 24.69 |
| Net Cash Flow | — | 0 | 0.02 | 0.23 | -0.27 | 0.33 | 4.61 | -1.62 | -2.34 |
| Free Cash Flow | — | 0 | -0.32 | -0.29 | -0.08 | 0 | -2.81 | 2.77 | -14.07 |
| CFO/EBITDA | — | 0 | -112 | -147 | 17 | 0 | -5 | 78 | -73 |
Ratios
| Particulars | Mar 2016 | Mar 2017 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12.99 | 14.14 | 7.4 | 12.34 | 19.55 | 82.69 | 80.9 | 68.26 | 59.03 |
| Inventory Days | 61.39 | 49.67 | 55.59 | 69.41 | 80.06 | 111 | 125 | 127 | 161 |
| Days Payable | 2.49 | 2.16 | 3.35 | 5.35 | 4.52 | 6.54 | 8.96 | 12.32 | 8.21 |
| Cash Conversion Cycle | 71.89 | 61.65 | 59.64 | 76.4 | 95.09 | 187 | 197 | 183 | 211 |
| Working Capital Days | 91.35 | 59.59 | 54.14 | 74.85 | 71.64 | 122 | 212 | 182 | 235 |
| ROCE % | — | 0.68% | — | 1.12% | 35.91% | 63.26% | 32.39% | 24.48% | 20.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Shelter Pharma insights
60 extracted metrics + investor summaries across FY16–FY26.
Documents
Frequently Asked Questions about Shelter Pharma
What does Shelter Pharma Ltd do?
Where is Shelter Pharma Ltd (SHELTER) listed?
Which sector does Shelter Pharma Ltd belong to?
What is the market capitalisation of Shelter Pharma Ltd?
What is the 52-week high and low of Shelter Pharma Ltd?
Does Shelter Pharma Ltd pay dividends?
What is the Return on Equity (ROE) of Shelter Pharma Ltd?
Company Information
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543963.md for Shelter Pharma Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.